Why This Fund Trimmed Million of TPB Despite Sales Surge
As Turning Point Brands rode a wave of rising oral nicotine sales, one fund made a bold move: trimming a multi-millio...
Fundamentals cover assigning every dollar a role, regular review, and disciplined adjustments to keep your finances on track.
18,222 articlesAs Turning Point Brands rode a wave of rising oral nicotine sales, one fund made a bold move: trimming a multi-millio...
Could Palantir be the kind of stock that defines a generation for long-term investors? This guide dives into the fact...
Could SoFi be the worst stock this year? This analysis highlights red flags, potential catalysts, and practical steps...
Ackman's bold pivot away from Alphabet toward AI bets has investors talking. This guide breaks down what happened, wh...
Alphabet is stepping up its AI game, signaling big potential and bigger risks for investors. This piece breaks down w...
A hidden AI stock is drawing quiet attention. This article breaks down why investors are eyeing it before its next ea...
DexCom and Insulet sit at the heart of diabetes technology. This in-depth look examines growth drivers, financials, a...
Broadcom has faced a stock pullback even as AI-driven revenue climbs. This article digs into the reasons behind the d...
Amazon’s biggest growth lever may not be its storefront. This article explains how AWS and AI spending could fuel a ...
Intel shares surged in premarket trading after President Trump floated a plan for Intel to build chips for Apple in t...
Investors dig into a mixed session as Amazon leads gains on Prime Day momentum and AI shopping activity. This guide b...
As SpaceX moves deeper into the public market, investors face a volatile ride. This article lays out credible scenari...